REG - Fevara PLC - Appointment of Sole Corporate Broker

FevaraAnnouncement

02/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260202:nRSB1954Ra&default-theme=true

RNS Number : 1954R  Fevara PLC  02 February 2026

 

2 February 2026

Fevara plc

 

 

Appointment of Sole Corporate Broker

 

 

Fevara plc (LSE: FVA), an international specialist in livestock supplements,
is pleased to announce the appointment of Canaccord Genuity Limited as Sole
Corporate Broker, with immediate effect.

 

 

For further information, please contact:

 

 Fevara plc                                    +44 (0) 1228 554 600
 Joshua Hoopes, Chief Executive Officer

 Gavin Manson, Chief Financial Officer

 Canaccord Genuity Limited (Corporate Broker)  +44 (0)20 7523 8000
 Max Hartley / Harry Rees

 Hudson Sandler (PR Adviser)                   +44 (0) 20 7796 4133
 Hattie Dreyfus / Nick Moore

 

About Fevara plc:

 

Fevara is an international specialist in livestock supplements.

 

Fevara's purpose is to empower farmers in extensive grazing systems with
research-proven products that boost profitability, improve resource efficiency
and support sustainable agriculture.  The Group develops, manufactures and
markets research-proven supplements, including feed licks, blocks, bagged
minerals, and boluses for cattle, sheep and horses, sold under recognised and
trusted brands, including Crystalyx(®), HorsLic(®)(,) Horslyx(®), Scotmin
Nutrition(®), SmartLic(®) and Tracesure® Advanced.

 

Headquartered in Carlisle, Cumbria, in the UK, Fevara has five manufacturing
sites in the UK, US and Brazil with three operational joint ventures in
Germany and the US. It serves customers in more than 20 countries through its
expansive international distribution and support network.

 

Fevara has been listed on the London Stock Exchange since 1972.

 

For more information, visit: www.fevara.com (http://www.fevara.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPBBGDDCXGDGLB



            Copyright 2019 Regulatory News Service, all rights reserved